Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

Cytokine

Volumn 40, Issue 3, 2007, Pages 216-225

  Moulin, David ^a   Donzé, Olivier ^b   Talabot Ayer, Dominique ^a   Mézin, Françoise ^a   Palmer, Gaby ^a   Gabay, Cem ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b Apotech Corporation   (Switzerland)

Author keywords

Cytokine; Inflammation; Mast cells

Indexed keywords

AUTACOID; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 33; MONOCYTE CHEMOTACTIC PROTEIN 1; RIBONUCLEASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; MAST CELL; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ANIMALS; BONE MARROW CELLS; CELL LINE; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKINS; MAST CELLS; MEMBRANE PROTEINS; MICE; PROSTAGLANDIN D2; PROTEIN BINDING; TH2 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36749026651     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.09.013     Document Type: Article

References (29)

1. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
2. Baekkevold E.S., Roussigne M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 163 (2003) 69-79
3. Werman A., Werman-Venkert R., White R., Lee J.K., Werman B., Krelin Y., et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci USA 101 (2004) 2434-2439
4. Trajkovic V., Sweet M.J., and Xu D. T1/ST2--an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev 15 (2004) 87-95
5. Moritz D.R., Rodewald H.R., Gheyselinck J., and Klemenz R. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J Immunol 161 (1998) 4866-4874
6. Oshikawa K., Kuroiwa K., Tago K., Iwahana H., Yanagisawa K., Ohno S., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164 (2001) 277-281
7. Brunner M., Krenn C., Roth G., Moser B., Dworschak M., Jensen-Jarolim E., et al. Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30 (2004) 1468-1473
8. Kuroiwa K., Arai T., Okazaki H., Minota S., and Tominaga S. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284 (2001) 1104-1108
9. Fraser A., Moore M., Jongbloed S., Gracie A., and McInnes I.B. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Ann Rheum Dis 65 (2006) A10
10. Malaviya R., Ikeda T., Ross E.A., Jakschik B.A., and Abraham S.N. Bacteria--mast cell interactions in inflammatory disease. Am J Ther 2 (1995) 787-792
11. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
12. Shelburne C.P., McCoy M.E., Piekorz R., Sexl V., Roh K.H., Jacobs-Helber S.M., et al. Stat5 expression is critical for mast cell development and survival. Blood 102 (2003) 1290-1297
13. Palmer G., Talabot-Ayer D., Szalay-Quinodoz I., Maret M., Arend W.P., and Gabay C. Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur J Immunol 33 (2003) 434-440
14. Brint E.K., Fitzgerald K.A., Smith P., Coyle A.J., Gutierrez-Ramos J.C., Fallon P.G., et al. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction. J Biol Chem 277 (2002) 49205-49211
15. Sweet M.J., Leung B.P., Kang D., Sogaard M., Schulz K., Trajkovic V., et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 166 (2001) 6633-6639
16. Leung B.P., Xu D., Culshaw S., McInnes I.B., and Liew F.Y. A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol 173 (2004) 145-150
17. Takezako N., Hayakawa M., Hayakawa H., Aoki S., Yanagisawa K., Endo H., et al. ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. Biochem Biophys Res Commun 341 (2006) 425-432
18. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., and Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 13 (1994) 1176-1188
19. Echtenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-77
20. Gurish M.F., Bryce P.J., Tao H., Kisselgof A.B., Thornton E.M., Miller H.R., et al. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol 172 (2004) 1139-1145
21. Johnston B., Burns A.R., and Kubes P. A role for mast cells in the development of adjuvant-induced vasculitis and arthritis. Am J Pathol 152 (1998) 555-563
22. Nigrovic P.A., and Lee D.M. Mast cells in inflammatory arthritis. Arthritis Res Ther 7 (2005) 1-11
23. Nigrovic P.A., Binstadt B.A., Monach P.A., Johnsen A., Gurish M., Iwakura Y., et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA 104 (2007) 2325-2330
24. Martinon F., and Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14 (2007) 10-22
25. Omoto Y., Tokime K., Yamanaka K., Habe K., Morioka T., Kurokawa I., et al. Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment. J Immunol 177 (2006) 8315-8319
26. Luster A.D., and Rothenberg M.E. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J Leukoc Biol 62 (1997) 620-633
27. Gordon J.R. Monocyte chemoattractant peptide-1 expression during cutaneous allergic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response. J Allergy Clin Immunol 106 (2000) 110-116
28. Yin H., Huang B.J., Yang H., Huang Y.F., Xiong P., Zheng F., et al. Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun 351 (2006) 940-946
29. Fagundes C.T., Amaral F.A., Souza A.L., Vieira A.T., Xu D., Liew F.Y., et al. ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 81 (2007) 492-499